Jean Francois Formela's Net Worth

$144 Thousand

Estimate Recalculated Nov 8, 2024 04:32PM EST

Who is Jean Francois Formela?

Jean Francois Formela does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., EXELIXIS INC, Intellia Therapeutics, Inc., Spero Therapeutics, Inc., Ikena Oncology, Inc., Translate Bio, Inc., Egalet Corp, NUVELO INC, ACHILLION PHARMACEUTICALS INC, NxStage Medical, Inc., SGX PHARMACEUTICALS, INC., Korro Bio, Inc., and DECODE GENETICS INC.

SEC CIK

Jean Francois Formela's CIK is 0001030575

Past Insider Trading and Trends

2021 was Jean Francois Formela's most active year for acquiring shares with 5 total transactions. Jean Francois Formela's most active month to acquire stocks was the month of May. 2021 was Jean Francois Formela's most active year for disposing of shares, totalling 4 transactions. Jean Francois Formela's most active month to dispose stocks was the month of August. 2020 saw Jean Francois Formela paying a total of $34,989.76 for 50,808 shares, this is the most they've acquired in one year. In 2021 Jean Francois Formela cashed out on 95,600 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HORIZON PHARMA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+28.97%
828.44K
$3.62
$2,999,957.79
3.69M
Mar 2
Form 4
∞
2.53M
$9.00
—
2.53M
Aug 2
Form 3
—
0
—
—
0
No matching records found

EXELIXIS INC (EXEL) Snapshot price: $25.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-31.99%
-275.00K
$7.78
-$2,138,990.00
584.52K
Sep 6 - Sep 7
Form 4
—
0
—
—
0
Apr 23
Form 4
-19.89%
-200.00K
$6.80
-$1,360,000.00
805.47K
Aug 11
Form 4
—
0
—
—
0
Apr 9
Form 4
-0.44%
-4.40K
$6.64
-$29,230.08
1.01M
Dec 5
Form 4
-1.98%
-20.40K
$7.00
-$142,759.20
1.01M
Dec 3
Form 4
-8.03%
-90.00K
$6.99
-$628,758.00
1.03M
Dec 2
Form 4
-21.67%
-310.00K
$6.64
-$2,059,547.00
1.12M
Dec 1
Form 4
-6.53%
-100.00K
$6.58
-$658,160.00
1.43M
Nov 28
Form 4
-1.60%
-24.90K
$6.50
-$161,947.11
1.53M
Nov 26
Form 4
-2.37%
-37.70K
$6.73
-$253,566.43
1.56M
Nov 25
Form 4
-6.46%
-110.00K
$6.40
-$704,462.00
1.59M
Nov 24
Form 4
-0.73%
-12.50K
$6.36
-$79,502.50
1.7M
Nov 21
Form 4
-0.15%
-2.50K
$6.50
-$16,250.00
1.72M
Nov 20
Form 4
-0.87%
-15.00K
$7.10
-$106,497.00
1.72M
Nov 13
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+248.19%
5.2K
—
—
7.29K
Jun 14
Form 4
-98.22%
-553.38K
$132.73
-$73,448,878.91
10K
Scheduled
Jun 28
Form 4
∞
2.09K
—
—
2.09K
Jun 23
Form 4
-15.18%
-201.72K
$88.15
-$17,558,773.95
1.13M
Scheduled
Jun 11 - Jun 14
Form 4
-0.59%
-4.51K
$85.43
-$385,545.59
765.1K
Scheduled
Apr 29
Form 4
-30.83%
-342.96K
$85.96
-$29,482,338.40
769.61K
Scheduled
Apr 26 - Apr 28
Form 4
-0.07%
-800.00
$84.98
-$67,984.00
1.11M
Scheduled
Apr 5
Form 4
-31.07%
-501.94K
$60.29
-$30,262,715.80
1.11M
Feb 26
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
May 21
Form 4
-100.00%
-6.69K
$31.17
-$208,397.27
0
Scheduled
Jul 16
Form 4
-100.00%
-6.69K
$27.96
-$186,908.24
0
Scheduled
Jun 19
Form 4
—
0
—
—
0
May 17
Form 4
-100.00%
-6.69K
$25.04
-$167,389.36
0
Scheduled
May 16
Form 4
-100.00%
-39.24K
$23.87
-$936,742.63
0
Mar 20
Form 4
-4.02%
-150.00K
$16.24
-$2,435,440.00
3.58M
Jul 7 - Jul 11
Form 4
—
0
—
—
0
May 18
Form 4
-100.00%
-21.13K
$13.91
-$293,842.63
0
Mar 9 - Mar 10
Form 4
∞
4.43M
—
—
4.43M
May 11
Form 4
—
0
—
—
0
May 5
Form 3
—
0
—
—
0
No matching records found

Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.3101

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 17
Form 4
—
0
—
—
0
Oct 27
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 5
Form 4
+5,528.97%
2.37M
$14.00
—
2.41M
Nov 6
Form 3
—
0
—
—
0
No matching records found

Ikena Oncology, Inc. (IKNA) Snapshot price: $1.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Dec 21
Form 4
+4.89%
98.72K
$15.34
$1,614,428.13
2.12M
Mar 30 - Dec 14
Form 4
+2,809.29%
4.75M
—
—
4.92M
Dec 21 - Mar 30
Form 3
—
0
—
—
0
No matching records found